Detalhe da pesquisa
1.
Comparison of circulating tumor DNA between African American and Caucasian patients with metastatic castrate-resistant prostate cancer post-abiraterone and/or enzalutamide.
Prostate
; 83(11): 1028-1034, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37113064
2.
Prediction of Resistance to 177Lu-PSMA Therapy by Assessment of Baseline Circulating Tumor DNA Biomarkers.
J Nucl Med
; 64(11): 1721-1725, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37770113